Ukwelashwa kwe-HIV e-Israel - Ngempumelelo AIDS Ukwelashwa Kwamanye Amazwe

ukwelashwa kwe-HIV e-Israel wukuqinisekisa ukuthi abantu abane-HIV bangaphila ukuphila okuvamile. elwa ne-HIV emsebenzini ngokunciphisa inani le-HIV egazini wegciwane. Umgomo nokwelashwa kwe-HIV: wegciwane. Lokhu kusho ukuthi emva kokwelashwa kwe-HIV phesheya, inani le-HIV egazini lincane kangangokuthi asikwazi ukutholwa ukuhlolwa okuvamile. Ukwehlisa inani le-HIV egazini kuyasiza ukuqinisa amasosha omzimba. Ayanda-CD4 cell count, ephansi ingozi yesifo obudalwa i-HIV, futhi mhlawumbe abanye nezinye izifo eziyingozi.

Kufanele uxoxe nodokotela wakho isikhathi esingcono kakhulu sokuba uqale ukwelashwa i-HIV phesheya. Kunezindlela eziningana zici ongase uthande ukucabangela, kuhlanganise: Inzuzo ukuqala ukwelashwa ngalesi sikhathi. izingozi ezingase zibe khona, uma kukhona ukubambezeleka ekuqaleni ukwelashwa. Usukulungele ukuqala ukwelashwa manje? Kunezinye izici empilweni yakho ezithinta ikhono kanye nesidingo ukuqala ukwelashwa AIDS e-Israel.

Ezimweni eziningi, sincoma izifundo ezigcwele ukwelashwa uma unesifo ngaphambi kokuba uqale ukwelashwa nge-HIV. Uma i-CD4 count imayelana 350, kutuswa ukuba uxoxe HIV nodokotela wakho futhi uqale ukwelashwa i-HIV e-Israel, lapho nje usukulungele. Ezinye iziguli zingase kube ukuhlakanipha ukuba uqale ukwelashwa uma i-CD4 yabo cell count namanje ephakeme kunaleyo 350, isibonelo, abantu abanale ukusha kwesibindi kohlobo B noma sokusha kwesibindi sohlobo C. Elinye iqembu labantu abangaba uqale ukwelashwa ngokushesha yilezo nge -HIV Rhesus ezingezinhle. Lokhu kungenxa yokuthi ekwelapheni ingculaza phesheya kunciphisa wegciwane futhi kunciphisa ingozi yokuthola igciwane lesandulela ngculaza.

ukwelashwa okujwayelekile kubantu kokuba ukwelashwa kwe-HIV okokuqala luyinhlanganisela izidakamizwa ezintathu. elwa ne-HIV eyakhe kwama-class ehlukene, kuye ngokuthi umsebenzi wabo ku-HIV. amakilasi amathathu ezinkulu izidakamizwa-HIV anti: nucleoside reverse transcriptase inhibitor (NRTIs), okungezona-nucleoside reverse transcriptase inhibitor (nama-NNRTI) kanye ritonavir protease inhibitor. Ithanda, inhlanganisela elwa ne-HIV izidakamizwa abantu ukuphuza imithi ye-HIV okokuqala yilona NNRTI-efavirenz (Sustiva) noma NRTI-tenofovir (Viread) kanye FTC (emtricitabine, Emtriva) kanye 3TC (lamivudine, Epivir) kanye abacavir (Ziagen).

FTC, bese TDF ehlangana futhi ngokuthi amaphilisi Truvada. 3TC (lamivudine, Epivir) kanye abacavir (Ziagen) Epzicom kufakwe tablet. Ngaphambi uthatha Kivexa okudingeka uyenze ukuhlolwa igazi ukuze uqinisekise akukho yokungezwani komzimba ukuze abacavir. Kivexa kungaba ukukhetha okuhle, uma kukhona ingozi yesifo senhliziyo. Futhi i-tenofovir akukwazi ungumuntu omuhle uma unezinkinga izinso. Uma i-efavirenz, tenofovir kanye ne-FTC, ngokushesha nje kokuwa legciwane egazini izinyanga okungenani eziyisithupha, ungashintsha futhi uthathe zontathu lezi izidakamizwa e-tablet inhlanganisela ngokuthi Atripla.

Esikhundleni i-efavirenz, ritonavir, kuyinto inhibitor protease. Amplified protease inhibitor kungaba indlela enhle uma i-HIV yokumelana nomuthi kufanele nama-NNRTI futhi NRTIs. Ekhethwayo kukhona protease inhibitor lopinavir, atazanavir (Reyataz), darunavir (Presista), fosamprenavir (Telzir) noma saquinavir (Invirase). Zonke lezi protease inhibitor kunyuke nge umthamo ehlukile ritonavir, lopinavir ngaphandle ukuthi kutholakala kuphela izibhebhe lihambisana ritonavir (Kaletra). Ama-integrase inhibitor raltegravir (Isentress), kanye inhibitor ka-CCR5 receptor maraviroc (Celsentri) ukuthi ivume abantu kokuba ukwelashwa kwe-HIV phesheya.

Abesifazane abaveli belulekwa ukuba uqale ukuphuza i-nevirapine uma amaseli e-CD4 yabo ukubala okukhulu kuka-250 ngenxa ingozi nemiphumela emibi kakhulu. AZT 3TC (Combivir) Kunconywa njengoba neminye imikhiqizo ezimbili abesifazane uhlela ukukhulelwa. Le mithi ezintathu yanconywa ngesikhathi sokukhulelwa, ngoba baye ibonakaliswa ukuzivikela ezinhle ukuvimbela ukudluliswa kwe-Martyr Omkhulu kusuka kumama kuya enganeni.